Trilogy Capital’s Celanese CE Stock Holding History

Trilogy Capital’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-43	Closed	-$5K	–	200
2018 Q3	$5K	Hold	43	–	–	﹤0.01%	396
2018 Q2	$5K	Hold	43	–	–	﹤0.01%	366
2018 Q1	$4K	Buy	+43	New	+$4.54K	﹤0.01%	326

Other funds holding CE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Trilogy Capital's CE Position: Q4 2018 in Review

Trilogy Capital sold out of Celanese (CE) in Q4 2018, closing a stake of 43 shares — an estimated $5K sold.

Trilogy Capital first reported a position in CE in Q1 2018 and held it in 3 quarters. The position peaked at $5K in Q3 2018. 523 funds tracked by Wall St. Rank hold CE as of Q4 2018.

Trilogy Capital reported no remaining Celanese position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 43 Celanese shares in Q4 2018, an estimated $5K.
Trilogy Capital first reported a position in Celanese in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Celanese position peaked at $5K in Q3 2018.
523 funds tracked by Wall St. Rank held Celanese as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.